Vivian Tamietti Martins
Federal University of Minas Gerais, Brazil
Tel: +5531 98496-1567
Leishmaniasis, Animal Models, Clinical trials, Vaccines
Graduated in Biological Sciences (2009). Master's and Ph.D degree in Biochemistry and Immunology (2016). Post-doctoral fellow in the Health Sciences Program: Infectious Diseases and Tropical Medicine (2017). Post-doctoral fellow in the Microbiology, Immunology and Infectious Diseases Program (2018). Specialist in the field of Molecular Biology; Immunology, Biotechnology and Parasitology, focusing on Diagnosis, Treatment and Vaccines for Leishmaniasis.
Vivian Tamietti Martins et al. A recombinant fusion protein displaying murine and human MHC class I- and IIspecific epitopes protects against Leishmania amazonensis infection. Cellular Immunology. (2017).
Vivian Tamietti Martins et al. A recombinant chimeric protein composed by human and mice-specific CD4+ and CD8+ T cell epitopes protects against visceral leishmaniasis. Parasite Immunol. (2017).
Vivian Tamietti Martins et al. A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis. Acta Trop. v. 154, p. 73-81 (2016).
Vivian Tamietti Martins et al. Antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of Leishmania infantum against visceral leishmaniasis. Plos One. v. 10, p. e0137683 (2015).